Somite AI
MA - BostonBiotechnology
Focus: Somite AI is an AI-driven cell therapy company focused on gene therapy and cell therapy development. The company is early-stage with limited public visibility on scale and market position.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Open Jobs
6+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Somite AI?
AI assessmentBest suited for early-career scientists or technologists seeking foundational experience in AI-driven cell therapy, but career progression and financial stability remain unproven.
Why Work Here
- Opportunity to work on cutting-edge AI-enabled cell therapy, an emerging frontier in biotechnology with significant commercial potential
- Small team environment (5 active roles) suggests hands-on involvement and broad impact in early-stage drug discovery
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Somite AI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.